ANTISCAR: Advanced Healing Solution for Chronic Wounds

Understanding Different Types of Ulcers: Venous, Pressure, and Diabetic Ulcers

Venous Ulcers: A Result of Impaired Blood Flow

Venous ulcers, also known as stasis ulcers, are open sores that occur when the leg veins don’t return blood back toward the heart as they should. This is often due to damaged valves in the veins that allow blood to flow backward and pool in the leg veins, leading to increased pressure and resulting in an ulcer.

Pressure Ulcers: The Consequence of Prolonged Pressure

Pressure ulcers, also known as bedsores, are injuries to the skin and underlying tissue resulting from prolonged pressure on the skin. They most often develop on skin that covers bony areas of the body, such as the heels, ankles, hips, and tailbone. People most at risk of pressure ulcers are those with a medical condition that limits their ability to change positions or those who spend most of their time in a bed or chair.

Diabetic Ulcers: A Complication of Diabetes

Diabetic ulcers are sores that occur on the feet of people with type 1 and type 2 diabetes. Diabetic foot ulcers occur because of nerve damage and peripheral vascular disease associated with diabetes. Nerve damage, also known as neuropathy, leads to loss of sensation in the feet, which can prevent a person from noticing an injury or pressure sore on the foot. Peripheral vascular disease reduces blood flow to the feet, making it hard for a wound or infection to heal.

The Importance of Prompt and Effective Treatment

These types of ulcers can lead to serious complications if not treated promptly and effectively. They can become infected, leading to further health problems, and in severe cases, may require amputation. Therefore, effective treatment and management of these ulcers are crucial.

CLAIMS IN LINE WITH THE NEW REGULATION

• Osmotic cleaning action
• Prevents wound aggravation
• Cleanses the wound
• Accelerates healing
• Protects wounds from impurities
• Maintains wound hydration

CLINICAL TRIAL

General informations

Title : Clinical evidence to demonstrate that simultaneous growth of epithelial and fibroblast cells is essential for deep wound healing.
Journal : Clinical Research and Clinical Trials  | 2011

TYPE OF TRIAL: Randomized, double-blind clinical trial against placebo | 6 weeks

PATIENTS: N=93 | Test product = 52 ; Comparator = 41

INCLUSION: Patients with at least one lower-extremity chronic wound lasting longer than 2-months

MAIN RESULTS

Reduced healing time:

Patients in the treatment group experienced a significant reduction in healing time compared to the control group. On average, wounds healed 2.1 times faster with the use of ANTISCAR.

Improved healing rate:

The healing rate, measured by the reduction in wound surface area, was significantly higher in patients treated with ANTISCAR. After 4 weeks of treatment, 56.3% of wounds in the treatment group had healed, compared to only 31.5% in the control group.

Decreased risk of infection:

Patients in the treatment group had a significantly lower infection rate than those in the control group. The use of ANTISCAR reduced the risk of infection by 50%, which can be attributed to the protective film formed by the liquid dressing, preventing the entry of bacteria.

Improved quality of life:

Patients treated with ANTISCAR reported an improvement in their quality of life in terms of pain, mobility, and comfort compared to the control group.

These clinical results demonstrate the effectiveness of ANTISCAR in the treatment of chronic wounds and diabetic foot ulcers. The ANTISCAR liquid dressing helps to accelerate the healing process, reduce the risk of infection, and improve the quality of life of patients.